Annual Accounts Receivable
$778.00 K
+$535.00 K+220.16%
December 31, 2023
Summary
- As of February 7, 2025, INBX annual accounts receivable is $778.00 thousand, with the most recent change of +$535.00 thousand (+220.16%) on December 31, 2023.
- During the last 3 years, INBX annual accounts receivable has risen by +$696.00 thousand (+848.78%).
- INBX annual accounts receivable is now at all-time high.
Performance
INBX Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$455.00 K
+$184.00 K+67.90%
September 30, 2024
Summary
- As of February 7, 2025, INBX quarterly accounts receivable is $455.00 thousand, with the most recent change of +$184.00 thousand (+67.90%) on September 30, 2024.
- Over the past year, INBX quarterly accounts receivable has increased by +$184.00 thousand (+67.90%).
- INBX quarterly accounts receivable is now -89.51% below its all-time high of $4.34 million, reached on June 30, 2019.
Performance
INBX Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
INBX Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +220.2% | +67.9% |
| 3 y3 years | +848.8% | +49.7% |
| 5 y5 years | +12.8% | +49.7% |
INBX Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +220.2% | -41.5% | +166.1% |
| 5 y | 5-year | at high | +848.8% | -41.5% | +9000.0% |
| alltime | all time | at high | +848.8% | -89.5% | +9000.0% |
Inhibrx Biosciences Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $455.00 K(+67.9%) |
| Jun 2024 | - | $271.00 K(+58.5%) |
| Mar 2024 | - | $171.00 K(-78.0%) |
| Dec 2023 | $778.00 K(+220.2%) | $778.00 K(+135.0%) |
| Sep 2023 | - | $331.00 K(+1.2%) |
| Jun 2023 | - | $327.00 K(+7.6%) |
| Mar 2023 | - | $304.00 K(+25.1%) |
| Dec 2022 | $243.00 K(-34.9%) | $243.00 K(0.0%) |
| Sep 2022 | - | $243.00 K(0.0%) |
| Jun 2022 | - | $243.00 K(-35.5%) |
| Mar 2022 | - | $377.00 K(+1.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $373.00 K(+354.9%) | $373.00 K(+210.8%) |
| Sep 2021 | - | $120.00 K(-44.7%) |
| Jun 2021 | - | $217.00 K(+502.8%) |
| Mar 2021 | - | $36.00 K(-56.1%) |
| Dec 2020 | $82.00 K(-58.8%) | $82.00 K(-88.0%) |
| Sep 2020 | - | $681.00 K(>+9900.0%) |
| Jun 2020 | - | $5000.00(-97.5%) |
| Dec 2019 | $199.00 K(-71.2%) | $199.00 K(-95.4%) |
| Jun 2019 | - | $4.34 M(+143.2%) |
| Mar 2019 | - | $1.78 M |
| Dec 2018 | $690.00 K(+392.9%) | - |
| Dec 2017 | $140.00 K | - |
FAQ
- What is Inhibrx Biosciences annual accounts receivable?
- What is the all time high annual accounts receivable for Inhibrx Biosciences?
- What is Inhibrx Biosciences annual accounts receivable year-on-year change?
- What is Inhibrx Biosciences quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Inhibrx Biosciences?
- What is Inhibrx Biosciences quarterly accounts receivable year-on-year change?
What is Inhibrx Biosciences annual accounts receivable?
The current annual accounts receivable of INBX is $778.00 K
What is the all time high annual accounts receivable for Inhibrx Biosciences?
Inhibrx Biosciences all-time high annual accounts receivable is $778.00 K
What is Inhibrx Biosciences annual accounts receivable year-on-year change?
Over the past year, INBX annual accounts receivable has changed by +$535.00 K (+220.16%)
What is Inhibrx Biosciences quarterly accounts receivable?
The current quarterly accounts receivable of INBX is $455.00 K
What is the all time high quarterly accounts receivable for Inhibrx Biosciences?
Inhibrx Biosciences all-time high quarterly accounts receivable is $4.34 M
What is Inhibrx Biosciences quarterly accounts receivable year-on-year change?
Over the past year, INBX quarterly accounts receivable has changed by +$184.00 K (+67.90%)